Koers Corbus Pharmaceuticals Holdings Inc OTC Bulletin Board
Aandelen
US21833P1030
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 401 mln. 374 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -53 mln. -49,33 mln. | Nettowinst (verlies) 2025 * | -65 mln. -60,5 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-7,34
x | K/w-verhouding 2025 * |
-7,46
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,31% |
Recentste transcriptie over Corbus Pharmaceuticals Holdings Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 49 | 01-07-13 |
Sean Moran
DFI | Director of Finance/CFO | 66 | 11-04-14 |
Chief Tech/Sci/R&D Officer | 50 | 28/02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alan Holmer
CHM | Chairman | 74 | 01-01-14 |
Avery Catlin
BRD | Director/Board Member | 75 | 01-08-14 |
Yuval Cohen
CEO | Chief Executive Officer | 49 | 01-07-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,65% | 103 mld. | |
+6,75% | 101 mld. | |
+6,58% | 23,07 mld. | |
-12,60% | 22,23 mld. | |
-5,48% | 18,05 mld. | |
-39,98% | 17,18 mld. | |
-10,17% | 16,94 mld. | |
+6,12% | 14,07 mld. | |
+35,47% | 12,35 mld. |
- Beurs
- Aandelen
- Koers CRBP
- Koers